video
An Introduction to Avacta Life Sciences
This video introduces Avacta Life Sciences, part of Avacta Group plc and its flagship product, Affimers - a revolutionary new, engineered alternative to antibodies...
List view / Grid view
Next Generation Sequencing (NGS)
news
An interview with Ben Busby, National Center for Biotechnology Information (NCBI)
26 May 2015 | By Oxford Global Conferences
In the run up to the Next Generation Sequencing USA Congress & co-located Single Cell Genomics and Transcriptomics USA Congress, Oxford Global Conferences interviewed Ben Busby, Genomics Outreach Coordinator, NCBI...
article
Data automation in large-scale omics-based biomedical research
Medicine and life sciences research are being revolutionised by major technological developments that have taken place over the past decade. High-throughput sequencers can now generate high-quality nucleotide sequence data at a small fraction of the cost compared to only a few years back...
article
NGS In-Depth Focus 2015
9 April 2015 | By Caroline Richards, Editor, Drug Target Review
In this NGS In-Depth Focus; How next-generation sequencing came to be, plus a brief history & Data management for large-scale NGS-based research projects...
news
TATAA Biocenter introduces partnership with Qlucore to use Qlucore Omics Explorer in its Next Generation Sequencing courses
10 March 2015 | By TATAA Biocenter and Qlucore
TATAA Biocenter, the world's premier organizer of hands-on training in molecular diagnostics and Europe´s leading provider of genomic services, has announced a partnership with Qlucore for the analyses of Next Generation Sequencing (NGS) data...
article
How next-generation sequencing came to be: a brief history
DNA sequencing technologies have come on leaps and bounds since the double-helical structure of DNA was first discovered in 1953 by genetics pioneers James Watson and Francis Crick. This discovery paved the way to the development, years later, of next generation sequencing (NGS), a high-throughput technology that enables scientists to…
news
AstraZeneca announces partnership with Illumina to develop next generation gene sequencing panel for companion diagnostic tests
27 August 2014 | By AstraZeneca
AstraZeneca announced that it has entered into a collaboration with gene sequencing company, Illumina, Inc., to develop its next generation sequencing platform for companion diagnostic tests applicable across AstraZeneca’s oncology portfolio...
news
Roche acquires Genia Technologies to strengthen next generation sequencing pipeline
2 June 2014 | By Roche
Roche announced the acquisition of Genia Technologies, Inc., a privately held company, based in Mountain View, California, USA...
article
Drug resistance mechanisms and target selection in disease treatment strategies
In November 2013, the US Food and Drug Administration (FDA) allowed for the first time the marketing of high-throughput DNA sequencing technology for diagnostic testing. It was a breakthrough year for Next Generation Sequencing (NGS)...
